转化失败:临床前研究未能准确预测区域镇痛对癌症复发的影响
本文探讨临床前研究提示区域麻醉可减少癌症复发,但四项随机试验共4770例患者显示区域镇痛未改善乳腺癌、肺癌和腹部癌症术后生存。作者分析临床前研究机制驱动和简化模型的局限导致假说错误,并总结实验室与临床试验脱节的教训。
要点
- 四项随机试验共4770例患者表明区域镇痛未改善乳腺癌、肺癌和腹部癌症生存结局。
- 临床前研究提示区域麻醉通过抑制手术应激、增强免疫、避免挥发性麻醉药和减少阿片类药物使用来抑制转移。
- 基础科学家和临床研究者均低估了临床前模型的局限性,导致错误假说。
核心结论
- 区域镇痛在乳腺癌、肺癌和腹部癌症患者中未改善生存结局,临床前研究的获益提示未能被临床验证。
研究设计与样本
- 本文为综述,分析临床前研究与临床试验结果不一致的原因及教训。
主要发现
- 2007年启动的一项大型临床试验基于临床前证据研究椎旁镇痛对乳腺癌复发的影响,但该试验及另外三项近期随机试验共4770例患者显示区域镇痛未改善生存结局。
- 临床前研究提示脊髓麻醉通过抑制手术应激、增强免疫反应、避免挥发性麻醉药和减少阿片类药物使用来抑制转移播散。
- 临床前研究与临床试验之间存在几乎完全的脱节,可能源于临床前研究由机制驱动并基于简化模型。
临床怎么用
- 临床决策应基于稳健的随机试验证据,而非仅凭临床前机制研究推断区域镇痛可减少癌症复发。
局限性
- 临床前研究由机制驱动并基于简化模型,基础科学家和临床研究者均低估了这些模型的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The major goal of translational research is to evaluate the efficacy and effectiveness of treatments and interventions that have emerged from exhaustive preclinical evidence. In 2007, a major clinical trial was started to investigate the impact of paravertebral analgesia on breast cancer recurrence. The trial was based on preclinical evidence demonstrating that spinal anesthesia suppressed metastatic dissemination by inhibiting surgical stress, boosting the immunological response, avoiding volatile anesthetics, and reducing opioid use. However, that trial and three more recent randomized trials with a total of 4,770 patients demonstrate that regional analgesia does not improve survival outcomes after breast, lung, and abdominal cancers. An obvious question is why there was an almost complete disconnect between the copious preclinical investigations suggesting benefit and robust clinical trials showing no benefit? The answer is complex but may result from preclinical research being mechanistically driven and based on reductionist models. Both basic scientists and clinical investigators underestimated the limitations of various preclinical models, leading to the apparently incorrect hypothesis that regional anesthesia reduces cancer recurrence. This article reviews factors that contributed to the discordance between the laboratory science, suggesting that regional analgesia might reduce cancer recurrence and clinical trials showing that it does not-and what can be learned from the disconnect.
引用
- Cata JP, Sessler DI. Lost in Translation: Failure of Preclinical Studies to Accurately Predict the Effect of Regional Analgesia on Cancer Recurrence. Anesthesiology. 2024. PMID: 38170786. doi:10.1097/ALN.0000000000004823
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。